MAX Chat
Company Analysis AbbVie
1. Summary
Advantages
- Dividends (3.24%) are higher than the sector average (1.28%).
- The stock's return over the last year (-1.36%) is higher than the sector average (-47.17%).
- Current debt level 49.68% is below 100% and has decreased over 5 years from 74.88%.
- The company's current efficiency (ROE=62.52%) is higher than the sector average (ROE=-83.32%)
Disadvantages
- Price (192.45 $) is higher than fair price (27.12 $)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| AbbVie | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.5% | -7.6% | 0.6% |
| 90 days | 1.9% | -45.3% | 19.2% |
| 1 year | -1.4% | -47.2% | 14.2% |
ABBV vs Sector: AbbVie has outperformed the "Healthcare" sector by 45.81% over the past year.
ABBV vs Market: AbbVie has significantly underperformed the market by -15.53% over the past year.
Stable price: ABBV is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ABBV with weekly volatility of -0.0261% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (192.45 $) is higher than the fair price (27.12 $).
Price is higher than fair: The current price (192.45 $) is 85.9% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (73.65) is higher than that of the sector as a whole (52.65).
P/E vs Market: The company's P/E (73.65) is higher than that of the market as a whole (61.8).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (93.66) is higher than that of the sector as a whole (10.87).
P/BV vs Market: The company's P/BV (93.66) is higher than that of the market as a whole (20.58).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (5.59) is higher than that of the sector as a whole (4.03).
P/S vs Market: The company's P/S indicator (5.59) is lower than that of the market as a whole (15.97).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (25.26) is higher than that of the sector as a whole (16.12).
EV/Ebitda vs Market: The company's EV/Ebitda (25.26) is higher than that of the market as a whole (18.72).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -1.48% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-1.48%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.87%).
5.4. ROE
ROE vs Sector: The company's ROE (62.52%) is higher than that of the sector as a whole (-83.32%).
ROE vs Market: The company's ROE (62.52%) is higher than that of the market as a whole (42.63%).
5.5. ROA
ROA vs Sector: The company's ROA (3.17%) is lower than that of the sector as a whole (6.38%).
ROA vs Market: The company's ROA (3.17%) is lower than that of the market as a whole (23.26%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (15.29%) is higher than that of the sector as a whole (15.06%).
ROIC vs Market: The company's ROIC (15.29%) is higher than that of the market as a whole (9.17%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 3.24% is higher than the average for the sector '1.28%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.24% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 3.24% has been growing over the last 5 years. Growth over 10 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (257.71%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
